Increasing brain tumor rates: is there a link to aspartame?

Area of Science:

• Neuro-oncology
• Toxicology
• Epidemiology

Background:

• Brain tumor incidence has risen in industrialized nations over the past two decades.
• National Cancer Institute data from 1975-1992 reveal two phases of brain tumor increase in the US.
• A recent sustained increase in incidence and malignancy suggests factors beyond improved diagnostics.

Purpose of the Study:

• To analyze trends in US brain tumor rates from 1975 to 1992.
• To investigate potential environmental factors contributing to the observed increase in brain tumor incidence and malignancy.
• To evaluate the artificial sweetener aspartame as a potential factor in the rise of brain tumors.

Main Methods:

• Analysis of National Cancer Institute brain tumor data (1975-1992).
• Comparison of temporal trends in brain tumor rates with the introduction of aspartame.
• Review of existing evidence on aspartame's potential carcinogenicity, including animal studies and mutagenicity data.

Main Results:

• Brain tumor increases occurred in two phases: an early modest rise possibly due to diagnostics, and a later sustained increase in incidence and malignancy.
• Aspartame is identified as a potential factor explaining the recent rise in brain tumor incidence and malignancy.
• Supporting evidence includes an animal study with high brain tumor rates in aspartame-fed rats and aspartame's mutagenic potential.

Conclusions:

• The recent increase in brain tumor incidence and malignancy warrants investigation into environmental factors.
• Aspartame presents a promising candidate for explaining these trends due to temporal association and preliminary evidence.
• Reassessment of aspartame's carcinogenic potential is necessary.